JNJ-39758979   Click here for help

GtoPdb Ligand ID: 8984

Synonyms: JNJ 39758979 | JNJ39758979
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: JNJ-39758979 is a selective histamine H4 receptor antagonist [4] with anti-inflammatory potential.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 2
Topological polar surface area 81.06
Molecular weight 221.16
XLogP 0.97
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES NC1CCN(C1)c1cc(nc(n1)N)C(C)C
Isomeric SMILES N[C@@H]1CCN(C1)c1cc(nc(n1)N)C(C)C
InChI InChI=1S/C11H19N5/c1-7(2)9-5-10(15-11(13)14-9)16-4-3-8(12)6-16/h5,7-8H,3-4,6,12H2,1-2H3,(H2,13,14,15)/t8-/m1/s1
1. Kollmeier A, Francke K, Chen B, Dunford PJ, Greenspan AJ, Xia Y, Xu XL, Zhou B, Thurmond RL. (2014)
The histamine H₄ receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects.
J Pharmacol Exp Ther, 350 (1): 181-7. [PMID:24817035]
2. Murata Y, Song M, Kikuchi H, Hisamichi K, Xu XL, Greenspan A, Kato M, Chiou CF, Kato T, Guzzo C et al.. (2015)
Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis.
J Dermatol, 42 (2): 129-39. [PMID:25491792]
3. Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WL, Stark H, Thurmond RL, Haas HL. (2015)
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.
Pharmacol Rev, 67 (3): 601-55. [PMID:26084539]
4. Savall BM, Chavez F, Tays K, Dunford PJ, Cowden JM, Hack MD, Wolin RL, Thurmond RL, Edwards JP. (2014)
Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H₄ receptor antagonists.
J Med Chem, 57 (6): 2429-39. [PMID:24495018]
5. Thurmond RL, Chen B, Dunford PJ, Greenspan AJ, Karlsson L, La D, Ward P, Xu XL. (2014)
Clinical and preclinical characterization of the histamine H(4) receptor antagonist JNJ-39758979.
J Pharmacol Exp Ther, 349 (2): 176-84. [PMID:24549371]